Armata Pharmaceuticals Inc

NYSE American: ARMP    
Share price (5/10/24): $2.86    
Market cap (5/10/24): $106 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Articles of Amendment of Armata Pharmaceuticals, Inc. Amended and Restated Articles of Incorporation
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Amended and Restated Bylaws of Armata Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 1 page Amendment to the Bylaws of Armata Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.5
from 10-Q 18 pages Amended and Restated Bylaws of Armata Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 98 pages Certificate of Merger
12/34/56
EX-3.1
from 8-K 8 pages Filed Secretary of State State of Washington Date Filed: 05/09/2019 Effective Date: 05/09/2019 Ubi No: 601 166 399 Articles of Amendment to Amended and Restated Articles of Incorporation of Ampliphi Biosciences Corporation
12/34/56
EX-3.1
from 8-K 1 page Articles of Amendment to Amended and Restated Articles of Incorporation of Ampliphi Biosciences Corporation
12/34/56
EX-3.2
from 10-Q 4 pages Statement of Correction to Articles of Amendment to Amended and Restated Articles of Incorporation of Ampliphi Biosciences Corporation
12/34/56
EX-3.1
from 8-K 2 pages Articles of Amendment to Amended and Restated Articles of Incorporation of Ampliphi Biosciences Corporation
12/34/56
EX-3.2
from 10-Q 23 pages First Amendment to Amended and Restated Bylaws of Ampliphi Biosciences Corporation
12/34/56
EX-3.1
from 10-Q 32 pages Targeted Genetics Corporation Amended and Restated Articles of Incorporation
12/34/56
EX-3.1
from 8-K 2 pages Articles of Amendment to Amended and Restated Articles Incorporation of Ampliphi Biosciences Corporation
12/34/56
EX-3.5
from 10-K 2 pages Articles of Amendment to Articles of Ampliphi Biosciences Corporation
12/34/56
EX-3.1
from 8-K 1 page First Amendment to Amended and Restated Bylaws of Ampliphi Biosciences Corporation
12/34/56
EX-3.4
from 10-12G 24 pages Amended and Restated Bylaws of Targeted Genetics Corporation
12/34/56
EX-3.3
from 10-12G 4 pages Articles of Correction Rcw 23b.01240
12/34/56
EX-3.2
from 10-12G 19 pages Articles of Amendment to Articles of Ampliphi Biosciences Corporation Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock
12/34/56
EX-3.1
from 10-12G 26 pages Targeted Genetics Coropration Amended and Restated Articles of Incorporation
12/34/56
EX-3.1
from 10-Q 13 pages Targeted Genetics Corporation Amended and Restated Articles of Incorporation
12/34/56